San Carlos, CA, United States of America

Dawn M Tanamachi

USPTO Granted Patents = 11 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 163(Granted Patents)

Location History:

Milpitas, CA (US) (2011 - 2012)
Miltpitas, CA (US) (2013)
San Carlos, CA (US) (2011 - 2022)

Company Filing History:

E. R. Squibb Sons, Inc.

patents

3 out of 3,685

Bristol-myers Squibb Compnay

where one patent can have more than one assignee

Years Active: 2011-2022

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11312777 - Human monoclonal antibodies that bind CXCR4 and uses thereof (2022-04-26),

2. 10106615 - Nucleic acids encoding human monoclonal antibodies that bind CXCR4 (2018-10-23),

3. 9499632 - Human antibodies that bind CD22 and uses thereof (2016-11-22),

4. 9220244 - Transgenic animals expressing chimeric antibodies for use in preparing human antibodies (2015-12-29),

5. 8481683 - Human antibodies that bind CD22 and uses thereof (2013-07-09),

6. 8450464 - Human monoclonal antibodies that bind CXCR4 (2013-05-28),

7. 8399647 - Alpha5-beta1 antibodies and their uses (2013-03-19),

8. 8232449 - Transgenic animals expressing chimeric antibodies for use in preparing human antibodies (2012-07-31),

9. 8097703 - CD19 antibodies and their uses (2012-01-17),

10. 8039596 - Alpha 5-beta 1 antibodies and their uses (2011-10-18),

11. 7910798 - Transgenic animals expressing chimeric antibodies for use in preparing human antibodies (2011-03-22),

Certainly! Here is the article about inventor Dawn M Tanamachi:

Title: Dawn M Tanamachi: Pioneering Innovation in Biotechnology

Introduction:

Dawn M Tanamachi, a visionary inventor based in San Carlos, CA, is a trailblazer in the world of technology. With a passion for innovation and a drive to create a better future through her inventions, Dawn has made significant contributions to the field of biotechnology.

Latest Patents:

Dawn M Tanamachi's latest patents showcase her expertise in biotechnology. Her patents include "Human monoclonal antibodies that bind CXCR4 and uses thereof," which provide isolated monoclonal antibodies that specifically bind to CXCR4 with high affinity. These antibodies have promising applications in treating various cancers, inflammatory disorders, and HIV infection. Another noteworthy patent is "Nucleic acids encoding human monoclonal antibodies that bind CXCR4," which further emphasizes Dawn's commitment to developing novel therapeutic solutions.

Career Highlights:

Throughout her career, Dawn M Tanamachi has worked with reputable companies such as Medarex Inc. and E.R. Squibb & Sons, Inc., where she has honed her skills and expertise in biotechnology. Her innovative approach to problem-solving and her dedication to advancing healthcare technologies have set her apart as a distinguished inventor in the industry.

Collaborations:

Dawn M Tanamachi has collaborated with esteemed coworkers, including Peter Brams and Josephine M Cardarelli, who have contributed their unique insights and expertise to her innovative projects. Together, they have explored new avenues in biotechnology and driven forward groundbreaking solutions to complex medical challenges.

Conclusion:

In conclusion, Dawn M Tanamachi's relentless pursuit of innovation and her exceptional contributions to the field of biotechnology solidify her as a leading figure in the world of technology. Her inventive spirit, coupled with her commitment to creating positive change through her inventions, inspires and empowers future generations of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.